Upon launching the Reach Campaign, PATH asked itself, “What’s next for an organization that’s changed the lives of 160 million people?” It answered simply: “Reach higher.” Okay, that’s a pretty broad statement, but even broader is Reach’s drive to balance the scales of global health disparities. PATH is doing this by taking aim at what it considers to be "top threats" in global health: focusing on high potential health solutions and directing its efforts toward women and children.
The campaign’s specific areas of focus include malaria, women’s reproductive health, maternal and newborn health, and child health. If this sounds all too familiar, that’s because it is. These are areas in which PATH has been working, and which the Gates Foundation has been supporting, for decades. So while this Reach Campaign is new in the fundraising sense, it isn’t really new in the sense of PATH's traditional areas of focus, save one matter—women’s non-communicable diseases (NCDs).
The Reach Campaign is addressing NCDs related to women in terms of cancers such as breast and cervical, diabetes, and heart disease. Cancer will be the top priority in this arena. Up until now, PATH's major areas of work have zeroed in on child survival and maternal and reproductive health.
In the disease arena, the organization has mainly worked in infectious rather than non-communicable diseases. Incidentally, these are all major global health programs at the Gates Foundation, and some credit PATH as a primary implementer of the foundation’s global health agenda. So dedicating more resources toward NCDs is the difference between this campaign and PATHs historical global health work.
PATH has already managed to raise over $75 million toward its $100 million goal from not only Gates, but the Hilton Foundation, Abbott Fund, the Margaret A. Cargill Foundation, and the Medtronic Foundation, just to name a few supporters. And that $15 million give from Gates? That’s small beans compared to the nearly $2.5 billion in grants the foundation has awarded to PATH since the mid-1990s.